Families First Counseling Center, Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 24178 First Avenue, Ste 2, Siren, WI 54872 Phone: 715-349-8913 Fax: 715-349-8981 |
Wesetern Region Recovery & Wellness Consortia Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 7410 County Road K, Siren, WI 54872 Phone: 715-349-7600 Fax: 715-349-2145 |
Access, Inc. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 24670 State Road 35 70, Suite 1200, Siren, WI 54872 Phone: 715-349-7233 Fax: 715-349-7205 |
Aurora Community Counseling Employee Support And Services, Inc. Social Worker Medicare: Not Enrolled in Medicare Practice Location: 24670 State Road 35 70, Suite 1200, Siren, WI 54872 Phone: 715-349-7233 Fax: 715-349-7205 |
Aurora Communtiy Counseling Employee Support & Services, Inc. Dba: Acc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 24670 State Road 35 70, Suite 1200, Siren, WI 54872 Phone: 715-349-7233 Fax: 715-349-7205 |
Northwest Counseling And Guidance Clinic- Siren Day Treatment Clinic - Adolescent and Children Mental Health Medicare: Not Enrolled in Medicare Practice Location: 24996 St Rd 35, Siren, WI 54872 Phone: 715-349-7069 Fax: 888-625-8634 |
Northwest Directions - Siren Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 7670 Johnson Street, Siren, WI 54872 Phone: 715-349-2829 Fax: 715-349-2737 |
News Archive
BrainStorm Cell Therapeutics Inc., an innovative developer of adult stem cell technologies and CNS therapeutics, announced today that it has signed an agreement with PharmaNet LLC, an inVentiv Health Company, to assist in the development of the protocol and IND file for submission to the FDA for approval of BrainStorm's ALS human clinical trials in the United States.
TVG is pleased to welcome leading biotech and pharma executives at the 18th Annual BioPartnering Europe, held in London, UK. To open the conference, Dr. Anders Ekblom, Executive Vice President, Global Medicines Development at AstraZeneca, spoke about a commitment to innovation and AstraZeneca's unique approach to collaborations.
A new study has examined whether different blood thinning medications prescribed to prevent strokes in patients with atrial fibrillation might increase the risk of heart attacks.
Researchers from the Hospital del Mar and Pompeu Fabra University have confirmed that messenger RNA vaccines pre-prepared in syringes for their administration can be transported by road for up to three hours.
› Verified 7 days ago